FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marcia Rupnow

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Activities & Behaviors

Geographic Areas

United States

Co-author Network

Publications

TOP 3
Jay Lin; Wing Chow; Myoung S Kim; Marcia F T Rupnow
Real-world treatment pattern and outcomes among patients who took tapentadol IR or oxycodone IR.
Michael J Marmura; Mary Hopkins; Jocelyn Andrel; William B Young; David M Biondi; Marcia F T Rupnow; Robert B Armstrong
Electronic medical records as a research tool: evaluating topiramate use at a headache center.
Marcia F T Rupnow; Alicia H Chang; RD Shachter; Douglas K Owens; Julie Parsonnet
Cost-effectiveness of a potential prophylactic Helicobacter pylori vaccine in the United States.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marcia Rupnow (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jay Lin; Wing Chow; Myoung S Kim; Marcia F T Rupnow
Real-world treatment pattern and outcomes among patients who took tapentadol IR or oxycodone IR.
Journal of medical economics 2013;16(5):685-90.
2010: Michael J Marmura; Mary Hopkins; Jocelyn Andrel; William B Young; David M Biondi; Marcia F T Rupnow; Robert B Armstrong
Electronic medical records as a research tool: evaluating topiramate use at a headache center.
Headache 2010;50(5):769-78.
2009: Marcia F T Rupnow; Alicia H Chang; RD Shachter; Douglas K Owens; Julie Parsonnet
Cost-effectiveness of a potential prophylactic Helicobacter pylori vaccine in the United States.
The Journal of infectious diseases 2009;200(8):1311-7.
2009: Dawn Buse; Marcia F T Rupnow; richard lipton
Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life.
Mayo Clinic proceedings. Mayo Clinic 2009;84(5):422-35.
2009: Julie Munakata; Elisabeth Hazard; Daniel Serrano; David Klingman; Marcia F T Rupnow; Jonothan Tierce; Michael Reed; richard lipton
Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
Headache 2009;49(4):498-508.
2009: Matthew J Page; L Clark Paramore; Dilesh Doshi; Marcia F T Rupnow
Evaluation of resource utilization and cost burden before and after an employer-based migraine education program.
Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine 2009;51(2):213-20.
2009: Debra A Wertz; Ralph M Quimbo; Avin Z Yaldo; Marcia F T Rupnow
Resource utilization impact of topiramate for migraine prevention in the managed-care setting.
Current medical research and opinion 2009;25(2):499-503.
2009: Elisabeth Hazard; Julie Munakata; Marcelo E Bigal; Marcia F T Rupnow; richard lipton
The burden of migraine in the United States: current and emerging perspectives on disease management and economic analysis.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2009;12(1):55-64.
2008: Avin Z Yaldo; Debra A Wertz; Marcia F T Rupnow; Ralph M Quimbo
Persistence with migraine prophylactic treatment and acute migraine medication utilization in the managed care setting.
Clinical therapeutics 2008;30(12):2452-60.
2008: Michael Dickson; Thomas J Bramley; CM Kozma; Dilesh Doshi; Marcia F T Rupnow
Potential drug-drug interactions with antiepileptic drugs in Medicaid recipients.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2008;65(18):1720-6.
2008: Brian F Leas; Joshua J Gagne; Neil I Goldfarb; Marcia F T Rupnow; Stephen Silberstein
Assessing quality of care for migraineurs: a model health plan measurement set.
Population health management 2008;11(4):203-8.
2008: Frederick G Freitag; Timothy Smith; Ninan T Mathew; Marcia F T Rupnow; Steven Greenberg; Lian Mao; Gary Finlayson; Pamela Wright; David Biondi
Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial.
Headache 2008;48(3):341-54.
2007: David W Dodick; Stephen Silberstein; Joel R Saper; Frederick G Freitag; Roger K Cady; Alan M Rapoport; Ninan T Mathew; Joseph Hulihan; Concetta Crivera; Marcia F T Rupnow; Lian Mao; Gary Finlayson; Steven J Greenberg
The impact of topiramate on health-related quality of life indicators in chronic migraine.
Headache 2007;47(10):1398-408.
2007: Marcia F T Rupnow; Andrew Greenspan; Georges Gharabawi; Colette Kosik-Gonzalez; Young Zhu; Stephen M Stahl
Incidence and costs of polypharmacy: data from a randomized, double-blind, placebo-controlled study of risperidone and quetiapine in patients with schizophrenia or schizoaffective disorder.
Current medical research and opinion 2007;23(11):2815-22.
2007: Sheryl I Zimmerman; Philip D Sloane; Christianna Williams; Debra Dobbs; Ratnavalli Ellajosyula; Alyssa Braaten; Marcia F T Rupnow; Daniel Kaufer
Residential care/assisted living staff may detect undiagnosed dementia using the minimum data set cognition scale.
Journal of the American Geriatrics Society 2007;55(9):1349-55.
2007: Jason C Cole; Peggy Lin; Marcia F T Rupnow
Validation of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ v. 2.1) for patients undergoing prophylactic migraine treatment.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2007;16(7):1231-7.
2007: Anthony L Feliu; Marcia F T Rupnow; Angela Blount; Stephen J Boccuzzi; James Vermilyea
Resource use associated with topiramate in migraine prophylaxis.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2007;64(14):1483-91.
2007: Scott C Flanders; Robert L Findling; Eric Youngstrom; Gahan J Pandina; Marcia F T Rupnow; Sarah E Jensik; Gabrielle A Carlson
Observed clinical and health services outcomes in pediatric inpatients treated with atypical antipsychotics: 1999-2003.
Journal of child and adolescent psychopharmacology 2007;17(3):312-27.
2007: Stephen D Silberstein; Anthony L Feliu; Marcia F T Rupnow; Angela C Blount; Stephen J Boccuzzi
Topiramate in migraine prophylaxis: long-term impact on resource utilization and cost.
Headache 2007;47(4):500-10.
2007: Kevin Hawkins; Sara Wang; Marcia F T Rupnow
Indirect cost burden of migraine in the United States.
Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine 2007;49(4):368-74.
2007: Sara Poston; Michael Dickson; Michael T Johnsrud; Marcia F T Rupnow; Joette M Gdovin; Thomas J Bramley; Robert B Armstrong
Topiramate prescribing patterns among medicaid patients: diagnosis, comorbidities, and dosing.
Clinical therapeutics 2007;29(3):504-18.
2007: Jennifer H Lofland; Joshua J Gagne; Laura T Pizzi; Marcia F T Rupnow; Stephen D Silberstein
Impact of topiramate migraine prophylaxis on workplace productivity: results from two US randomized, double-blind, placebo-controlled, multicenter trials.
Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine 2007;49(3):252-7.
2007: Carl G H Dahlöf; Elizabeth Loder; Merle Diamond; Marcia F T Rupnow; George Papadopoulos; Lian Mao
The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials.
Health and quality of life outcomes 2007;5():56.
2006: Jeffrey Brown; Marcia F T Rupnow; Peter Neumann; Mark Friedman; Joseph Menzin
Cost effectiveness of topiramate in the prevention of migraines in the United States: an update.
Managed care interface 2006;19(12):31-8.
2006: Jan Lewis Brandes; David B Kudrow; John F Rothrock; Marcia F T Rupnow; Diane L Fairclough; Steven J Greenberg
Assessing the ability of topiramate to improve the daily activities of patients with migraine.
Mayo Clinic proceedings. Mayo Clinic 2006;81(10):1311-9.
2006: Steven G Potkin; Georges Gharabawi; Andrew Greenspan; Ramy A Mahmoud; Colette Kosik-Gonzalez; Marcia F T Rupnow; Cynthia A Bossie; Michael Davidson; Victoria Burtea; Young Zhu; Jintendra K Trivedi
A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization.
Schizophrenia research 2006;85(1-3):254-65.
2006: Georges Gharabawi; Andrew Greenspan; Marcia F T Rupnow; Colette Kosik-Gonzalez; Cynthia A Bossie; Young Zhu; Amir Kalali; A George Awad
Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: data from a randomized double-blind trial.
BMC psychiatry 2006;6():45.
2006: Sonja V Sorensen; Gregory de Lissovoy; Dan Kunaprayoon; Barbara Resnick; Marcia F T Rupnow; Stephanie Studenski
A taxonomy and economic consequences of nursing home falls.
Drugs & aging 2006;23(3):251-62.
2005: Steven G Potkin; Georges Gharabawi; Andrew Greenspan; Marcia F T Rupnow; Colette Kosik-Gonzalez; Gary Remington; Charles Ruetsch; Dennis Revicki
Psychometric evaluation of the Readiness for Discharge Questionnaire.
Schizophrenia research 2005;80(2-3):203-12.
2005: Natalie C Edwards; Julie C Locklear; Marcia F T Rupnow; Ronald J Diamond
Cost effectiveness of long-acting risperidone injection versus alternative antipsychotic agents in patients with schizophrenia in the USA.
PharmacoEconomics 2005;23 Suppl 1():75-89.
2005: Leslie A Lenert; Marcia F T Rupnow; Christine Elnitsky
Application of a disease-specific mapping function to estimate utility gains with effective treatment of schizophrenia.
Health and quality of life outcomes 2005;3():57.
2005: Natalie C Edwards; Marcia F T Rupnow; Chris L Pashos; Marc F Botteman; Ronald J Diamond
Cost-effectiveness model of long-acting risperidone in schizophrenia in the US.
PharmacoEconomics 2005;23(3):299-314.
2004: Leslie A Lenert; Ann P Sturley; Mark H Rapaport; Shannon Chavez; Penny E Mohr; Marcia F T Rupnow
Public preferences for health states with schizophrenia and a mapping function to estimate utilities from positive and negative symptom scale scores.
Schizophrenia research 2004;71(1):155-65.
2004: Montserrat Vera-Llonch; Thomas E Delea; Erin Richardson; Marcia F T Rupnow; Amy Grogg; Gerry Oster
Outcomes and costs of risperidone versus olanzapine in patients with chronic schizophrenia or schizoaffective disorders: a Markov model.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2004;7(5):569-84.
2004: Ira R Katz; Marcia F T Rupnow; Chris Kozma; Lon S Schneider
Risperidone and falls in ambulatory nursing home residents with dementia and psychosis or agitation: secondary analysis of a double-blind, placebo-controlled trial.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2004;12(5):499-508.
2004: Lori Frank; Leah Kleinman; Gabrielle Ciesla; Marcia F T Rupnow; Henry Brodaty
The effect of risperidone on nursing burden associated with caring for patients with dementia.
Journal of the American Geriatrics Society 2004;52(9):1449-55.
2004: Leah Kleinman; Lori Frank; Gabrielle Ciesla; Marcia F T Rupnow; Henry Brodaty
Psychometric performance of an assessment scale for strain in nursing care: the M-NCAS.
Health and quality of life outcomes 2004;2():62.
2003: William S Edell; Marcia F T Rupnow
Inpatient length of stay and atypical antipsychotic use among elderly patients with psychiatric disorders and Alzheimer's disease.
Managed care interface 2003;16(5):64-7.
2003: Leslie A Lenert; Ann Sturley; Marcia F T Rupnow
Toward improved methods for measurement of utility: automated repair of errors in elicitations.
Medical decision making : an international journal of the Society for Medical Decision Making 2003;23(1):67-75.